Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

How we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China

How we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China

Our client’s vaccine to protect against a condition prevalent in older adults had recently launched and secondary research was required to enable them to understand more about their target healthcare consumer and attitudes to health, well-being and vaccination. They needed to build a complete picture of how consumers are influenced, such as whether they are more influenced by HCP advice or online forums and social media. Furthermore they needed to develop an understanding for other out-of-pocket (OOP) competitor vaccines and what the future healthcare initiatives mean for vaccination in general.
 

read more »

How we conducted conference research to understand physician reactions to abstracts presented in a virtual setting

How we conducted conference research to understand physician reactions to abstracts presented in a virtual setting

Our client had planned to present new scientific data from its growing oncology portfolio and research pipeline at the Annual Meeting of The American Society of Clinical Oncology (ASCO).

Our client had planned to present new scientific data from its growing oncology portfolio and research pipeline at the Annual Meeting of The American Society of Clinical Oncology (ASCO). Data from a range of programmes were to be featured in more than 50 abstracts, including company-sponsored and collaborative research studies. However, as a result of the ongoing COVID-19 global pandemic, the annual event was converted from a physical setting to a virtual meeting. Market research was required to understand physician’s reaction to the abstracts presented in a virtual setting.

read more »

How we supported forecasting for a new vaccine by identifying the optimal pricing strategy

How we supported forecasting for a new vaccine by identifying the optimal pricing strategy

Our client was looking to identify the price point that would maximise revenue from their new vaccine across 8 emerging markets in Latin America and Asia Pacific, as well as establish long-term projections for their forecasting model. In parallel, they needed to ensure widespread and rapid market penetration of the vaccine, taking into account factors such as consumer socio-economic group, age and household composition.
 

read more »

How we conducted rare disease patient research during the COVID-19 lockdown in China

How we conducted rare disease patient research during the COVID-19 lockdown in China

Our client needed to conduct a small number of qualitative interviews in China with patients diagnosed with a rare condition which affects children and young adults. The results of the survey were time critical as they were needed to inform a protocol being published in 30 working days. We faced two key challenges, firstly to find, screen and recruit diagnosed patients with a prevalence of 0.9 per 100,000 and secondly to achieve this during the restrictions of the COVID-19 lockdown in 2020.
 

read more »

How we used online bulletin boards and an advisory board to help our client understand the dynamics of the payer environment

How we used online bulletin boards and an advisory board to help our client understand the dynamics of the payer environment

Our client had a product for the treatment and prophylaxis of bleeding in patients with Haemophilia A. Although the market had been stable, it was expected to change somewhat significantly as new products were due to be launched.

These new products would focus on the prophylaxis market and were expected to have better clinical and economic outcomes. There were opportunities and challenges for our client as the market was already competitive with many products already available. They needed to leverage the key value messages for their product to capitalise on the opportunities. As such, they needed to understand the dynamics of the payer environment and required competitor analysis to develop their communication strategy.

read more »